Cargando…
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
There are still unmet medical needs in the treatment of glioblastoma, the most common and the most aggressive glioma of all brain tumors. Here, we found that O-acetyl GD2 is expressed in surgically resected human glioblastoma tissue. In addition, we demonstrated that 8B6 monoclonal antibody specific...
Autores principales: | Fleurence, Julien, Cochonneau, Denis, Fougeray, Sophie, Oliver, Lisa, Geraldo, Fanny, Terme, Mickaël, Dorvillius, Mylène, Loussouarn, Delphine, Vallette, François, Paris, François, Birklé, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173050/ https://www.ncbi.nlm.nih.gov/pubmed/27172791 http://dx.doi.org/10.18632/oncotarget.9226 |
Ejemplares similares
-
Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
por: Fleurence, Julien, et al.
Publicado: (2017) -
Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia
por: Terme, Mickaël, et al.
Publicado: (2014) -
A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
por: Alvarez-Rueda, Nidia, et al.
Publicado: (2011) -
Anti-Gb3 Monoclonal Antibody Inhibits Angiogenesis and Tumor Development
por: Desselle, Ariane, et al.
Publicado: (2012) -
Biology of GD2 ganglioside: implications for cancer immunotherapy
por: Machy, Pierre, et al.
Publicado: (2023)